TuHURA Biosciences, Inc.

HURA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Assets
Cash & Equivalents $6.6M $6.2M $1.8M $4.8M $4.1M $17.8K $15.0K
Accounts Receivable — — — — — — —
Inventory — — — — $250.0K — —
Total Current Assets $7.9M $6.3M $2.6M — — — —
Property, Plant & Equipment — — — — — — —
Goodwill — — — — — — —
Intangible Assets (Excl. Goodwill) $40.3K $36.0K — — — — —
Total Assets $7.9M $6.4M $2.6M $5.0M $4.3M $182.8K $10.7K
Liabilities
Accounts Payable $1.2M $584.0K $762.3K $244.9K $140.5K $677.6K —
Total Current Liabilities $1.3M $627.4K $853.1K $299.9K $249.5K $1.1M —
Long-Term Debt $28.1K $693.7K — — — — —
Total Liabilities $1.3M $1.5M $3.4M $5.9M $5.1M $1.5M $0
Stockholders' Equity
Retained Earnings $-41.1M $-32.2M $-18.6M $-14.3M — — —
Total Stockholders' Equity $6.6M $4.9M $-821.5K $-901.2K $-818.0K $-1.3M $-877.1K
← Newer Page 2 of 2 Older →